AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2025
Mar 19, 2025
30583_dirs_2025-03-18_6cbfdb0a-6844-4882-b989-e7beb365c976.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2025-03-14
Reporting Person: Burkhart Erin (GVP, Chief Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-14 | Common Stock | F | 823 | $69.44 | Disposed | 12282 | Direct |
| 2025-03-17 | Common Stock | A | 5970 | — | Acquired | 18252 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-17 | Stock Option (Right to Buy Common Stock) | $71.55 | A | 9230 | Acquired | 2035-03-16 | Common Stock (9230) | Direct |
Footnotes
F1: Restricted stock units granted March 17, 2025. Price not applicable.
F2: Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19